BCL11B (down regulated 12-fold) is a tumor suppressor that is widely mutated in acute lymphocytic leukemia [40] and has recently been shown to be methylated, and thus likely down-regulated, in prostate cancers [41]. Here, BCL11B is linked to Familial prostate cancer.